MTOR and Hepatic steatosis: For instance, Hatori et al. have shown that 8-h TRF reduced hepatic steatosis and hyperinsulinemia through cAMP-response element binding protein, mTOR (mammalian target of rapamycin) and AMP-activated protein kinase pathways in mice [11].